Skip to main content
. 2021 Jun 7;6:225. doi: 10.1038/s41392-021-00631-2

Table 3.

Diverse vectors for targeted delivery highlighted in this review

Vectors Synthetic inner cores Payloads Targeting mechanisms/sites Indications References
RBC membrane MSNs Dox Laser-activated tumor-specific accumulation Breast cancer 43
PLGA RAP EPR effect in atherosclerotic lesions Atherosclerosis 18
Nanocrystals DTX Tumor-targeting ligands Glioma 47
Cationic liposomes AmB Specific affinity between pathogenic fungi and erythrocytes Fungal infection 53
CCM Aluminum phosphate nanoparticles CpG Lymph node-resident APCs Melanoma 14
Calcium pyrophosphate nanoparticles - Targeting to dendritic cells Melanoma 75
Porous Au@Rh ICG Homologous targeting Breast cancer 78
PLGA ICG Homologous targeting Breast cancer 79
Au nanostars Dox Homologous targeting Melanoma 81
Boron nitride nanotubes Dox Homologous targeting Glioblastoma 83
MSNs Dox Homologous targeting Prostate cancer 85
Gelatin nanoparticles Cisplatin Homologous targeting Head and neck squamous cell carcinoma 86
Neutrophil membrane Polycaprolactonepoly(ethylene glycol) nanoparticles Sparfloxacin Inflammatory targeting Inflammation 15
PLGA - Binding to immunoregulatory molecules Rheumatoid arthritis 87
Cationic liposome MTX Targeting to macrophages Inflamed skeletal muscle; ischemic heart 92
Poly(latic-co-glycolic acid) nanoparticles Carfilzomib CTC- and niche-targeting Cancer metastasis 98
NK cell membrane Liposomes Dox Targeting tumor cells with the help of NK cell markers Breast cancer 23
mPEG-PLGA nanoparticles TCPP Binding of tumor-targeting proteins Primary and abscopal tumor 88
Carboxylate terminated PLGA Gd lipid Tumor-homing natural killer cell membrane Tumor imaging 16
Macrophage membrane UCNPs - Cell-cell adhesion for cancer targeting Breast cancer 103
Liposome Emtansine

α4β1 integrin-VCAM-1

interactions

Lung metastasis of breast cancer 89
Hollow bismuth selenide nanoparticles Quercetin CCL2/CCR2- mediated recruitment Lung metastasis of breast cancer 106
PEGylation nanoparticle PTX IGF1R targeting ligand Breast cancer 17
Platelet membrane DSPE-PEG polymers Gevokizumab Infarct-homing ability of platelets Acute myocardial infarction 110
Porous metal-organic framework nanoparticles siRNA Tumor-targeting capability of platelets Breast cancer 19
Myeloid-derived suppressor cell membrane Iron oxide magnetic nanoparticles - MDSC with high affinity to melanoma Melanoma 111
Platelet-RBC hybrid membrane Liposome Chlorin e6 and tirapazamine Biomimetic surface molecules Melanoma and lung metastasis 112
RBC-cancer hybrid membrane CuS nanoparticles Dox Homologous targeting Melanoma 114
RBC-cancer hybrid membrane - Melanin nanoparticles Homologous targeting Breast cancer 317
Macrophage-derive Exo - SPION and Cur Neuropilin-1-targeted peptide Glioma 134
MSCs-derived Exo EGNPs - Binding of glucose and GLUT-1 glucose transporter CT imaging of acute striatal stroke 136
Normal fibroblast-like mesenchymal cell-derived Exo - siRNA or shRNA RNA payloads specific to oncogenic KrasG12D Pancreatic cancer 141
Exo PEGylated nanoparticles V2C QDs RGD-targeting tumor cells and TAT peptides targeting nucleus Breast cancer 144
Tumor-derived Exo PEG-PCL NPs PTX-S-LA and CuB High affinity between CCM and homotypic Exo membrane Breast cancer metastasis 152
Tumor cell-derived Exo - mRNAs Targeting peptides Glioma 153
Dendritic cell-derived Exo - siRNA Lamp2b fused to the neuron-specific RVG peptide Alzheimer’s disease 160
Macrophages-derived Exo - Catalase Surface adhesion proteins Parkinson’s disease 159
Exo - Biologically active proteins Floxed reporter cells Brain diseases 163
Exo - Oligonucleotides drugs Muscle-targeting peptide Dystrophin deficiency 165
Tumor cell-derived MVs - MTX Attracting neutrophils CCA 173
DCs-derived MVs - PTX Aptamer AS1411 targeting nucleolin Breast cancer 177
CCM-derived MVs Extremely small-sized iron oxide nanoparticles Glucose oxidase Homologous and RGD-targeting Hepatocellular carcinoma 179
SV40-VNPs - QDs and Hirulog Targeting peptides Atherosclerotic plaques 200
HBc VNPs - ICG RGD-targeting tumor cells Glioblastoma 204
AAV - VEGF Targeting to myocardium Ischemic myocardial disease 208
HBc VNPs - Dox Integrin αvβ3-mediated targeting Glioblastoma 215
Dd VNPs - Dox or cap analog Targeting liver cancer cells Hepatocellular carcinoma 217
RVG-hybrids VNPs QDs and pH-responsive dendrimers Dox and Pb RVG-guided and hierarchical targeting Orthotopic brain tumor 221
FMD VNPs - Dox RGD-targeting tumor cells Carcinoma of the uterine cervix 224
Qβ VNPs - RNAi Peptide targeting to tumor cells Glioblastoma 235
Qβ VNPs - Azithromycin Ligands targeting lung-resident macrophages Pulmonary infections 244
P22 VNPs - Cas9 and a single-guide RNA Targeting to specific cell Genetic diseases 247
MS2 VNPs - mRNA Inducing specific immunity Prostate cancer 254
TMV VNPs - PhenPt Tumor-homing ability of AR engineering Triple-negative breast cancer 263
TMV VNPs - Silencer GFP siRNA Passive targeting Hepatoma 270
CPMVVNPs - MTO Targeting to cerebral endothelial cells Glioblastoma 284